Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Rallybio Corporaton (NQ: RLYB ) 1.000 +0.010 (+1.01%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Rallybio Corporaton < Previous 1 2 3 4 5 6 Next > Rallybio Reports Third Quarter 2024 Financial Results and Provides Business Updates November 07, 2024 From Rallybio Corporation Via Business Wire Rallybio Announces Approval of Clinical Trial Applications for Phase 2 Trial of RLYB212 in Pregnant Women at Higher Risk of Alloimmunization and FNAIT October 29, 2024 From Rallybio Corporation Via Business Wire Data Demonstrating ENPP1 Inhibition as a Therapeutic Approach for Later-onset Hypophosphatasia Presented at the American Society for Bone and Mineral Research 2024 Annual Meeting September 30, 2024 From Rallybio Corporation Via Business Wire RLYB Stock Earnings: Rallybio Beats EPS for Q1 2024 May 09, 2024 RLYB stock results show that Rallybio beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the American Society of Human Genetics 2024 Annual Meeting September 23, 2024 From Rallybio Corporation Via Business Wire Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit September 10, 2024 From Rallybio Corporation Via Business Wire Fierce Names Rallybio to the 2024 Fierce 50 List as an Innovation Honoree September 09, 2024 From Rallybio Corporation Via Business Wire Rallybio Announces Publication of RLYB212 Phase 1 Proof-of-Concept Study Results in Thrombosis and Haemostasis August 29, 2024 From Rallybio Corporation Via Business Wire Rallybio to Present at Upcoming Investor Conferences August 27, 2024 From Rallybio Corporation Via Business Wire RLYB Stock Earnings: Rallybio Misses EPS for Q2 2024 August 08, 2024 RLYB stock results show that Rallybio missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates August 08, 2024 From Rallybio Corporation Via Business Wire Rallybio to Present at the 2024 Jones Healthcare Seaside Summit July 09, 2024 From Rallybio Corporation Via Business Wire Rallybio Announces Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations June 17, 2024 From Rallybio Corporation Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session June 06, 2024 Via Benzinga 3 Sorry Biotech Stocks to Sell in May While You Still Can May 31, 2024 Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell. Via InvestorPlace 3 Biotech Stocks to Sell in May Before They Crash & Burn May 10, 2024 Discover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio. Via InvestorPlace Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates May 09, 2024 From Rallybio Corporation Via Business Wire Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference May 07, 2024 From Rallybio Corporation Via Business Wire FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting April 17, 2024 From Rallybio Corporation Via Business Wire 12 Health Care Stocks Moving In Monday's Intraday Session April 15, 2024 Via Benzinga Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session April 12, 2024 Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session April 12, 2024 Via Benzinga Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet April 12, 2024 The weekly Benzinga Stock Whisper Index highlights five stocks that saw increased interest from readers. Here are this week's stocks to watch. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday April 12, 2024 Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning! Via InvestorPlace Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket April 12, 2024 Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year Via Benzinga Nasdaq Jumps 250 Points; Crude Oil Down 1% April 11, 2024 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83.... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session April 11, 2024 Via Benzinga Dow Dips 100 Points; CarMax Earnings Miss Views April 11, 2024 U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday. Via Benzinga Topics Earnings Stocks Exposures Financial US Equities Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday April 11, 2024 U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session. Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
